Boston Scientific introduces Endura Weight Loss Solutions

Boston Scientific has introduced its Endura Weight Loss Solutions representing a range of weight loss procedures, including endoscopic sleeve gastroplasty (ESG), endoscopic intragastric balloon placement using the Orbera Intragastric Balloon System and Transoral outlet reduction (TORe). The procedures do not involve any external incisions or scars and are designed to reduce the amount of space in the stomach, allowing patients to eat less, feel full faster and stay full longer.

Boston Scientific has introduced its Endura Weight Loss Solutions representing a range of weight loss procedures, including endoscopic sleeve gastroplasty (ESG), endoscopic intragastric balloon placement using the Orbera Intragastric Balloon System and Transoral outlet reduction (TORe). The procedures do not involve any external incisions or scars and are designed to reduce the amount of space in the stomach, allowing patients to eat less, feel full faster and stay full longer.

“At Boston Scientific, we’re advancing science in ways that make a real difference in people’s health,” said Dr Brian Dunkin, chief medical officer, Endoscopy, Boston Scientific. “Losing weight is personal – no single method is going to work for everyone. By introducing Endura Weight Loss Solutions we’re meeting people where they are. It’s a new name for a different kind of approach – one that is clinically supported and minimally invasive for those who may not want to undergo surgery or take weight loss medications long-term.”

During placement of the Orbera balloon, performed under anaesthesia, a deflated balloon is passed through the mouth and positioned in the stomach. Once in place, it is filled with sterile saline to approximately the size of a grapefruit, taking up space so patients feel full sooner and stay full longer. After six months, it’s removed in a similar, simple procedure.

In a clinical study, people who received an ESG procedure typically went home the same day as the procedure and returned to routine daily activities within two to three days. Similarly, the Orbera balloon is typically placed during an outpatient procedure and people return to routine daily activities within several days to a week. Clinical evidence has demonstrated that these procedures can lead to effective and proven weight loss when used in conjunction with lifestyle changes, including healthy eating and exercise.

TORe is a revision of a Roux-en-Y gastric bypass to reduce the size of the gastrojejunal outlet as well as the gastric pouch opening. This procedure helps induce satiety for patients.

To increase awareness of endoscopic weight loss options for people living with obesity, the company is launching a companion initiative: Break Through, a US consumer media campaign that addresses some of the concerns voiced by women in the survey. The campaign shines a spotlight on minimally invasive weight loss procedures that may help qualified people break through the mental and physical barriers of dieting, high-cost weight loss medications and surgical fear and try a new approach.